|
Post by dreamboatcruise on Nov 25, 2015 10:34:41 GMT -5
I see that many of these entries indicate MO for mail order. Anyone know if these prescriptions would show up in the Symphony and IMS numbers? I believe they have actual data from at least some of the MO services. The numbers they are presenting are supposedly estimates of total sales, so they are using statistical methods to fill in gaps. I believe I remember reading that IMS (the one with more complete data) is collecting data for about 80% of sales and estimating the rest. I think at this point that MO would account for over 20%, hence an indicator they have some data for MO. Regardless of exact level of accuracy there is no escaping the trend, which would seem to clearly indicate the number of actively prescribing doctor is climbing very slowly or stagnant.
|
|
|
Post by dreamboatcruise on Nov 25, 2015 10:42:45 GMT -5
I used to be a developer writing an app for doctors to write prescriptions on PDA (Smartphone minus phone) in 2008. ST for the app mean that no restriction IF there is a previous prescription for the same or different medicine on the same indication (symptom) or the doctor will have to check a box, select a reason from a list to over ride. Unless things changed , then it was't a big deal at all. No approval from the insurance company. There is no "creteria". The doctor does not have to prove anything to anybody. It is basically totally up to the doctor . I've seen a couple of the requirements forms and they were indeed more complicated. For one (I believe Tricare) I actually looked up the form and posted it here. It was like an IRS form... 1) if blah blah skip to 6 else go to 2... where many paths ended in "rejected". Granted this was as a step therapy that required the form to be submitted and approved so perhaps that isn't what is labeled ST. I don't know whether a defined criteria that still needs a rubber stamp is ST or PA. It seems many payers require at least failure on two orals, and perhaps some contraindication to SQ.
|
|
|
Post by rrtzmd on Nov 25, 2015 12:07:01 GMT -5
Looking through these, I noted that none of them mentioned the 12U dose. I haven't seen it mentioned anywhere else recently either. What happened to that?
|
|
|
Post by lakers on Nov 25, 2015 14:34:08 GMT -5
|
|
|
Post by bloodrootfc on Nov 25, 2015 14:40:18 GMT -5
Tier 3 not going to cut it. They need Tier 2. Can happen one of two ways: reduce price by 50% or show additional clinical data that gives Afrezza a classification other than Rapid-Acting
|
|
|
Post by dreamboatcruise on Nov 25, 2015 14:40:35 GMT -5
lakers... can you find a 2015 to compare? If that is one that has changed from restricted to not that would be great news.
|
|
|
Post by dreamboatcruise on Nov 25, 2015 14:43:27 GMT -5
Tier 3 not going to cut it. They need Tier 2. Can happen one of two ways: reduce price by 50% or show additional clinical data that gives Afrezza a classification other than Rapid-Acting Why do you think tier 3 will not have large impact. There is a discount card which will make tier 3 basically same cost as tier 2 for most patients (at least I think that would cover most). That would allow scrips to grow and then a year or two down the road when the clinically superiority of Afrezza is evident it would be much easier for SNY to negotiate tier 2... and perhaps while still commanding a real premium over whatever SQ RAA was also tier 2. To me that seems like a better long term plan (if possible to get on tier 3 now) vs cutting the price 50%.
|
|
|
Post by bloodrootfc on Nov 25, 2015 14:44:16 GMT -5
I really hate this company right now. Are you serious??? CEO tapped out while the artillery barrage is falling!!! I am outraged.
|
|
|
Post by doodyfree on Nov 25, 2015 14:44:43 GMT -5
|
|
|
Post by bloodrootfc on Nov 25, 2015 14:45:11 GMT -5
They should have raised cash at $5. At $2, they are in the danger zone. Going to penny land. Crap.
|
|
|
Post by lakers on Nov 25, 2015 14:44:54 GMT -5
Attachment DeletedHealthSpan Medicare Core 2 2016 Formulary www.healthspan.org/uploads/forms/H6298_15_032_Final_01_Core_2_Comprehensive_Formulary.pdfPg. 37 No Restriction. AFREZZA INHALATION CARTRIDGE, W/INHALATION DEVICE 4 UNIT, 4 UNIT (30)/ 8 UNIT (60), 4 UNIT (60)/ 8 UNIT (30) HealthSpan’s Formulary The formulary below provides coverage information about the drugs covered by HealthSpan. If you have trouble finding your drug in the list, turn to the Index that begins on page I-1. The first column of the chart lists the drug name. Brand name drugs are capitalized (e.g., ALBENZA) and generic drugs are listed in lower-case italics (e.g., amoxicillin). The information in the Requirements/Limits column tells you if HealthSpan has any special requirements for coverage of your drug.
|
|
|
Post by doodyfree on Nov 25, 2015 14:47:34 GMT -5
Someone needs to make a table of all the info, and make it sticky on top. Will be difficult to dig through the results after a few more pages.
|
|
|
Post by doodyfree on Nov 25, 2015 14:49:36 GMT -5
lakers, thanks a lot for digging these up, really appreciate your work. keep it going.
|
|
|
Post by dreamboatcruise on Nov 25, 2015 14:51:05 GMT -5
formularylookup.com seems to already have it at tier 3 without restriction, so this doesn't appear to be the long awaited Godot... oops, I mean improvement.
|
|
|
Post by lakers on Nov 25, 2015 14:51:16 GMT -5
Someone needs to make a table of all the info, and make it sticky on top. Will be difficult to dig through the results after a few more pages. For the skeptical crowd, they need to see a link to pdf, and pictures,...
|
|